Trial Profile
A Safety Study of Freeze-dried Rabies Vaccine(MRC-5 Cell)in Chinese Humans From 10-60 Years Old
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2016
Price :
$35
*
At a glance
- Drugs Rabies vaccine Beijing Minhai Biotechnology (Primary)
- Indications Rabies
- Focus Adverse reactions
- Sponsors Beijing Minhai Biotechnology
- 19 Jan 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Nov 2014 New trial record